A team of researchers at Penn State College of Medicine has developed an AI algorithm called EXPRESSO.

EXPRESSO surpasses existing methods in predicting and treating autoimmune diseases.

The algorithm analyzes genetic data, including gene expressions and regulations.

EXPRESSO has identified 26% more novel gene associations, offering potential therapeutics for conditions like lupus and rheumatoid arthritis.

By integrating 3D genomic data and epigenetics, EXPRESSO can pinpoint cell-specific effects.

This capability leads to the discovery of drug compounds that could reverse gene expression in autoimmune disease-related cell types.

The team is now focused on validating their findings in clinical trials.

This research brings hope for more effective treatments for autoimmune diseases.